L1CAM was demonstrated to be involved in different pro-tumor events such as metastasis, epithelial-to-mesenchymal transition (EMT), and is associated with aggressive tumor phenotypes, and chemoresistance [19,22,23,24,25,26]. Here, L1CAM is linked to neoplasm.